Histidine

SCHEMBL3750030

C[C@@H](OC(=O)[C@@H](N)CCCNC(=N)N)[C@H](N)C(=O)O.NC(=O)CC[C@H](N)C(=O)O.NC(=O)C[C@H](N)C(=O)OC(=O)[C@@H]1CCCN1.N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

	gene	UniProt	supporting neighbours	confidence
▸	KLK7	P49862	1/20	0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Histidine SCHEMBL2513267	0.87	—	—
Arginine SCHEMBL18042250	0.86	TUBB4A (0.32)	—
Arginine SCHEMBL18042252	0.86	TUBB4A (0.33)	—
Arginine SCHEMBL18042246	0.85	TUBB4A (0.33)	—
Arginine SCHEMBL18042247	0.84	C5AR1 (0.33)	—
Arginine SCHEMBL18042259	0.84	TUBB4A (0.33)	—
Arginine SCHEMBL18042249	0.84	C5AR1 (0.33)	—
Arginine SCHEMBL18042251	0.84	TUBB4A (0.35)	—
Histidine SCHEMBL7765125	0.83	—	—
Arginine SCHEMBL18042243	0.83	MC4R (0.33)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2101804-B1	PRO-ANGIOGENIC PEPTIDES	SUSAVION BIOSCIENCES INC (US)	2016-02-17	—	—	EP	disclosed
US-7838497-B2	Pro-angiogenic peptides	SUSAVION BIOSCIENCES, INC. (US)	2010-11-23	—	—	US	disclosed
EP-2101804-A2	PRO-ANGIOGENIC PEPTIDES	Susavion Biosciences, Inc. (US)	2009-09-23	—	—	EP	disclosed
US-20080233081-A1	PRO-ANGIOGENIC PEPTIDES	SUSAVION BIOSCIENCES, INC. (US)	2008-09-25	—	—	US	disclosed
WO-2008076815-A2	PRO-ANGIOGENIC PEPTIDES	SUSAVION BIOSCIENCES, INC. (US)	2008-06-26	—	—	WO	disclosed